You are here: Industry Insights > BioNTech

News List

Gov’t launches study on COVID-19 vaccine dose interval for pregnant women pharmatimes
August 06, 2021
A new clinical trial investigating the optimal gap between first and second COVID-19 vaccine doses for pregnant women is set to launch in England 3rd.
16- and 17-year-olds should receive first COVID-19 vaccine, advises JCVI pharmatimes
August 06, 2021
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all 16 and 17 year olds receive their first dose of the Pfizer-BioNTech vaccine.
BioNTech Acquires Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Maryland americanpharmaceuticalreview
August 05, 2021
BioNTech SE and Kite, a Gilead Company announced the closing of the acquisition of the solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility’s assets and leases in Gaithersburg, MD, from Kite.
More than 85 million COVID vaccines administered across the UK, reports DHSC pharmatimes
August 03, 2021
A total of 85,196,986 doses of a COVID-19 vaccine have been administered in the UK according to the latest figures, with 46,851,145 people receiving a first dose (88.6%) and 38,345,841 people receiving both doses (72.5%).
DHL Express delivers US donation of 1.5m Pfizer-BioNTech Covid-19 vaccine doses to Thailand prnasia
July 30, 2021
DHL Express, the world's leading express service provider today successfully delivered the first batch of 1.5 million Pfizer-BioNTech's Covid-19 vaccine doses donated by the United States government to Thailand.
BioNTech to develop a mRNA-based malaria vaccine pharmatimes
July 28, 2021
BioNTech has announced that the launch of a new project aimed a developing a ‘highly effective’ mRNA-based malaria vaccine candidate.
BioNTech Update on Sustainable Solutions to Infectious Disease in Africa americanpharmaceuticalreview
July 28, 2021
BioNTech SE announced the launch of its Malaria project, which aims to develop a well-tolerated and highly effective Malaria vaccine and implement sustainable vaccine supply solutions on the African continent.
Researchers find extending the time between Pfizer doses boosts antibodies pharmatimes
July 27, 2021
UK researchers have found that extending the time between the first and second doses of the Pfizer/BioNTech COVID-19 vaccine boosted antibodies against all variants of the virus tested compared to a short dosing interval.
COVID-19 vaccine market set to reach $19.5bn by 2026 pharmaceutical-technology
July 26, 2021
The size of the COVID-19 vaccine market across the seven major markets – the US, Germany, France, Italy, Spain, the UK, and Japan -will increase from $13.6bn in 2021 to $19.5bn in 2026 at a compound annual growth rate (CAGR) of 7.6% should annual ...
U.S. Govt. Buys Additional 200M Doses of Pfizer-BioNTech COVID Vax contractpharma
July 26, 2021
The U.S. government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine, expected to be delivered from October 2021 through April 2022.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page